Better Personalized Prostate Cancer Treatment In The Offing With New Testing Method
A new diagnostic method being studied to find detect and predict the aggressiveness and relapse of cancer originating from the prostate gland is showing promising result. This test and study is being carried out presently in the University Of Pittsburgh School Of Medicine.
A new formula is developed by the researchers so as to enable medical professionals to predict cancer that will relapse after treatment and also how aggressive it is for the body.
This new study is being supported by Dr David Samadi, one of the best known Urologist and Senior personal at the Popular Mount Sinai Medical Center. Here are more details about this new test for prostate cancer:
World-renowned prostate surgeon, Dr. David Samadi, may soon have the equation he needs to strengthen his approach to personalized medicine and prostate cancer treatment. Researchers at the University of Pittsburgh School of Medicine developed a new prostate cancer diagnostic formula to accurately predict the lifecycle of a man’s prostate cancer.
Beyond confirming the presence of prostate cancer, this new test gives unprecedented insight into the cancer’s aggressiveness and the likelihood of relapse after treatment. By conducting genetic analysis of copy number variations (CNV) in the tumor cells, the cells of the surrounding benign tissue, and the blood cells, experts were able to predict the prostate cancer’s path with as much as 81 percent accuracy.
“This may be the magic mix we need to fully understand prostate cancer once it’s diagnosed,” expressed Dr. Samadi. “Being able to unlock the aggressiveness of each unique diagnosis and then tailor surgery and other treatments accordingly will elevate how we eradicate prostate cancer exponentially.”
The prostate specific antigen (PSA) blood test and follow-up biopsy receive ongoing scrutiny for their diagnostic limitations. Despite even the government poking holes in these tests, Dr. Samadi remains a steadfast proponent of their effectiveness. “The PSA test and the biopsy are the best prostate cancer indicators we have today,” said Dr. Samadi. “As an expert, my job is to educate men about their disease and offer the most personalized and effective care possible.”
As Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, Dr. Samadi’s robotic prostate removal surgery is one of the most effective prostate cancer treatment options available. Using his custom SMART (Samadi Modified Advanced Robotic Technique) surgery he has successfully removed over 4,000 cancerous prostates. Read the full extract here.
So, there are lots of expectations that this test will improve personalized Prostate cancer treatment for men. More support should be provided so that this test could be validated. It is important to mention that this new test could bring about less invasive, less rigorous and less painful diagnostic methods. Hence, men can now be saved from that entire trauma.
Finally, Dr.Samadi applies a less invasive approach to remove prostate gland affected by cancer. This new test can be said to be inline with he does to provide better treatments for men.
This HUGE 4+ Year Old Prostate Cancer Victory Authority Website:
(95% of these 1,000+ Prostate Cancer Articles on this website
are written by our Expert In -house Writers, after lots of research.
The remaining 5% are news articles and videos from relevant sources!)
- Prostate Cancer Testing, Staging, Treatment and Prognosis
- New More Effective PSA Test Method For Detecting Prostate Cancer?
- MRI and Prostate Cancer Testing